BBOT BridgeBio Oncology Therapeutics, Inc.
BridgeBio Oncology Therapeutics, Inc. (BBOT) Institutional Ownership
What the institutions did with BBOT last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| Cormorant Asset Management, LP | 17.9M | 30.2% |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 4.9M | 8.3% |
| Omega Fund Management, LLC | 3.3M | 5.6% |
| EcoR1 Capital, LLC | 2.8M | 4.8% |
| Alphabet Inc. | 2.8M | 4.8% |
| WELLINGTON MANAGEMENT GROUP LLP | 2.8M | 4.7% |
| ENAVATE SCIENCES GP, LLC | 2.6M | 4.4% |
| CITADEL ADVISORS LLC | 2.6M | 4.4% |
| NOVO HOLDINGS A/S | 2.3M | 3.8% |
| BlackRock, Inc. | 2.2M | 3.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | 3.4% |
| Laurion Capital Management LP | 2.0M | 3.4% |
| ARMISTICE CAPITAL, LLC | 1.8M | 3.0% |
| STATE STREET CORP | 1.0M | 1.8% |
| Aisling Capital Management LP | 1.0M | 1.7% |
| Opaleye Management Inc. | 700.0K | 1.2% |
| GEODE CAPITAL MANAGEMENT, LLC | 622.4K | 1.1% |
| Granahan Investment Management, LLC | 558.5K | 0.9% |
| SPHERA FUNDS MANAGEMENT LTD. | 461.0K | 0.8% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 400.0K | 0.7% |
| ROYCE & ASSOCIATES LP | 384.9K | 0.7% |
| Catalio Capital Management, LP | 318.4K | 0.5% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 300.0K | 0.5% |
| VANGUARD FIDUCIARY TRUST CO | 291.5K | 0.5% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 286.5K | 0.5% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 538.4K | 2.0M | +1.5M |
| Paradigm Biocapital Advisors LP | Sold Out | 868.2K | 0 | -868.2K |
| STATE STREET CORP | Increased | 226.3K | 1.0M | +810.3K |
| Octagon Capital Advisors LP | Sold Out | 719.0K | 0 | -719.0K |
| Opaleye Management Inc. | Increased | 53.3K | 700.0K | +646.7K |
| EVENTIDE ASSET MANAGEMENT, LLC | Sold Out | 541.2K | 0 | -541.2K |
| SPHERA FUNDS MANAGEMENT LTD. | New | 0 | 461.0K | +461.0K |
| ARMISTICE CAPITAL, LLC | Increased | 1.3M | 1.8M | +436.0K |
| Granahan Investment Management, LLC | Increased | 231.0K | 558.5K | +327.5K |
| Catalio Capital Management, LP | New | 0 | 318.4K | +318.4K |
| Ikarian Capital, LLC | Sold Out | 270.2K | 0 | -270.2K |
| ROYCE & ASSOCIATES LP | Reduced | 636.5K | 384.9K | -251.6K |
| MILLENNIUM MANAGEMENT LLC | Reduced | 266.0K | 105.5K | -160.5K |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 437.9K | 300.0K | -137.9K |
| Hudson Bay Capital Management LP | Sold Out | 110.0K | 0 | -110.0K |
| Woodline Partners LP | Sold Out | 103.7K | 0 | -103.7K |
| BNP PARIBAS FINANCIAL MARKETS | Increased | 90.8K | 191.2K | +100.3K |
| CITADEL ADVISORS LLC | Increased | 2.5M | 2.6M | +89.1K |
| Palumbo Wealth Management LLC | New | 0 | 85.6K | +85.6K |
| NORTHERN TRUST CORP | Increased | 102.3K | 186.5K | +84.2K |
| BOOTHBAY FUND MANAGEMENT, LLC | Sold Out | 80.9K | 0 | -80.9K |
| Laurion Capital Management LP | Increased | 1.9M | 2.0M | +80.0K |
| HighVista Strategies LLC | Sold Out | 78.2K | 0 | -78.2K |
| BANK OF AMERICA CORP /DE/ | New | 0 | 77.1K | +77.1K |
| Brevan Howard Capital Management LP | Increased | 14.2K | 88.9K | +74.6K |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.